Development of a Multi-Antigenic SARS-CoV-2 Vaccine Using a Synthetic Poxvirus Platform

Modified Vaccinia Ankara (MVA) is a highly attenuated poxvirus vector that is widely used to develop vaccines for infectious diseases and cancer. We developed a novel vaccine platform based on a unique three-plasmid system to efficiently generate recombinant MVA vectors from chemically synthesized D...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Res Sq
Egile Nagusiak: Chiuppesi, Flavia, Salazar, Marcela d’Alincourt, Contreras, Heidi, Nguyen, Vu, Martinez, Joy, Park, Soojin, Nguyen, Jenny, Kha, Mindy, Iniguez, Angelina, Zhou, Qiao, Kaltcheva, Teodora, Levytskyy, Roman, Ebelt, Nancy, Kang, Tae, Wu, Xiwei, Rogers, Tom, Manuel, Edwin, Shostak, Yuriy, Diamond, Don, Wussow, Felix
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Journal Experts 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7373143/
https://ncbi.nlm.nih.gov/pubmed/32702732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21203/rs.3.rs-40198/v1
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak